Kazuhiro Kajiyama

6PUBLICATIONS
12CO-AUTHORS
Respiratory diseasesSocial epidemiologyRecommender systemsDisease surveillanceForensic epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 22, 2025
Cardiovascular Risk of Romosozumab vs. Teriparatide: A Cohort Study Using Japan's National Claims Database.

Hotaka Maruyama, Eiko Iwasa, Shinya Watanabe

|Jun 06, 2025
Risk of Thrombocytopenia by SSRIs or SNRIs in Patients With Depression Based on MID-NET: A Cohort Study in Japan.

|Apr 02, 2025
New Function for Safety Signal Monitoring in MID-NET®: The Case of an Anti-COVID-19 Drug.

Yusuke Okada, Takashi Ando, Fumitaka Takahashi

|Dec 02, 2024
Risk of artery dissection during systemic exposure to vascular endothelial growth factor pathway inhibitors.

Jun Okui, Takashi Waki, Kazuhiro Kajiyama

|Jan 17, 2023
Characterizing Granulocytopenia Associated with Thiamazole in Patients with Hyperthyroidism Based on Real-World Data from the MID-NET in Japan.

Yuki Kinoshita, Kazuhiro Kajiyama, Chieko Ishiguro

|Jul 25, 2019
Cardiovascular risks associated with dipeptidyl peptidase-4 inhibitors monotherapy compared with other antidiabetes drugs in the Japanese population: A nationwide cohort study.

Maki Komamine, Kazuhiro Kajiyama, Chieko Ishiguro

Pageof 1

Frequent Collaborators

5 joint publications

Yoshiaki Uyama

3 joint publications

Tomoaki Hasegawa

2 joint publications

Chieko Ishiguro

2 joint publications

Yusuke Okada